Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations Growth (1y) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 60.84% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 85.14% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -15.72% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 74.39% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.53% |
| Jun 30, 2025 | -85.61% |
| Mar 31, 2025 | -106.11% |
| Dec 31, 2024 | -82.12% |
| Sep 30, 2024 | -94.29% |
| Jun 30, 2024 | -14.64% |
| Mar 31, 2024 | 47.29% |
| Dec 31, 2023 | 19.41% |
| Sep 30, 2023 | 0.95% |
| Jun 30, 2023 | 36.21% |
| Mar 31, 2023 | -42.39% |
| Dec 31, 2022 | 23.16% |
| Sep 30, 2022 | -945.44% |
| Jun 30, 2022 | 30.23% |
| Mar 31, 2022 | 51.33% |
| Dec 31, 2021 | 46.76% |
| Sep 30, 2021 | 103.14% |
| Jun 30, 2021 | 34.12% |
| Mar 31, 2021 | 20.98% |
| Dec 31, 2020 | 19.23% |